For those taking the highest doses of Biogen’s experimental drug aducanumab, a year of treatment reduced amyloid plaques, in red on the left, a hallmark of Alzheimer’s disease.
For those taking the highest doses of Biogen’s experimental drug aducanumab, a year of treatment reduced amyloid plaques, in red on the left, a hallmark of Alzheimer’s disease. Sevigny et al./Nature TNS
For those taking the highest doses of Biogen’s experimental drug aducanumab, a year of treatment reduced amyloid plaques, in red on the left, a hallmark of Alzheimer’s disease. Sevigny et al./Nature TNS

Alzheimer’s drug offers a bit of hope, but it’s no cure

September 26, 2016 2:13 PM

More Videos

  • Time for the city to step up and fix discrimination problems in the fire department, attorney says

    Kansas City Missouri firefighter Tarshish Jones and attorneys Lynne Bratcher and Erin Vernon react after a jury awarded Jones over $350,000 in compensatory damages following a race discrimination suit over promotions in the fire department.